ホーム ＞ 研究活動 ＞ 研究業績 ＞ 治験管理室

研究業績・治験管理室[2009年度]

原著論文

  1. Watanabe N, Omori IM, Nakagawa A, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA: Safety reporting and adverse-event profile of mirtazapine described in randomized controlled trials in comparison with other classes of antidepressants in the acute-phase treatment of adults with depression: Systematic review and meta-analysis. CNS Drugs 2009; 24:35-53
  2. Sado M, Knapp M, Yamauchi K, Fujisawa D, So M, Nakagawa A, Kikuchi T, Ono Y: Cost-effectiveness of combination therapy versus antidepressant therapy for management of depression in japan. Aust N Z J Psychiatry 2009; 43:539-547
  3. Omori IM, Watanabe N, Nakagawa A, Akechi T, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA: Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: Meta-analysis. J Psychopharmacol 2009; 23:539-550
  4. Nakajima S, Ishida T, Akaishi R, Takahata K, Kitahata R, Uchida H, Suzuki T, Takeuchi H, Nomura K, Nakagawa A, Watanabe K, Kashima H: Impacts of switching antidepressants after successful electroconvulsive therapy on the maintenance of clinical remission in patients with treatment-resistant depression: A chart review. J ECT 2009; 25:178-181
  5. Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA: Milnacipran versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009: CD006529
  6. Nakagawa A, Grunebaum MF, Oquendo MA, Burke AK, Kashima H, Mann JJ: Clinical correlates of planned, more lethal suicide attempts in major depressive disorder. J Affect Disord 2009; 112:237-242
  7. Cipriani A, Santilli C, Furukawa TA, Signoretti A, Nakagawa A, McGuire H, Churchill R, Barbui C: Escitalopram versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009; CD006532
  8. Cipriani A, La Ferla T, Furukawa TA, Signoretti A, Nakagawa A, Churchill R, McGuire H, Barbui C: Sertraline versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009; CD006117
  9. Cipriani A, Furukawa TA, Salanti G, Geddes JR, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, McGuire H, Tansella M, Barbui C: Comparative efficacy and acceptability of 12 new-generation antidepressants: A multiple-treatments meta-analysis. Lancet 2009; 373:746-758
  10. 奥村泰之, 三澤史斉, 中林哲夫, 伊藤弘人: 統合失調症患者への非定型抗精神病薬治療と糖尿病のリスク メタ分析. 臨床精神神経薬理. 2010; 13:255-263
  11. 中川敦夫: 若手による研究最前線 現状と課題 うつ病における不安のcomorbidityと自殺行動の関連性. 不安障害研究 2009; 1:147-150
  12. 中川敦夫: 日本における認知行動療法の効果研究の現状と課題 大うつ病における通常治療と併用療法(通常治療+認知行動療法)の有効性および費用対効果に関する単盲検多施設共同ランダム化並行群間比較試験(e-cam研究). 認知療法研究 2009; 2:15-17
  13. 中林哲夫, 中村治雅, 岡本長久: 本邦における国際共同治験の現状と課題 –抗うつ薬開発の最近の動向-. 臨床精神神経薬理 2010; 13:255-263

総説

  1. Barbui C, Cipriani A, Furukawa TA, Salanti G, Higgins JP, Churchill R, Watanabe N, Nakagawa A, Omori IM, Geddes JR: Making the best use of available evidence: The case of new generation antidepressants: A response to: Are all antidepressants equal? Evid Based Ment Health 2009; 12:101-104
  2. 中村治雅: 臨床研究をめぐる国内と海外の現状, 臨床薬理2009, 40(4), 137-140

著書

  1. 中村治雅: 筋ジストロフィー患者登録データーベース特にDuchene型筋ジストロフィーに関連して. 小児筋疾患診療ハンドブック 診断と治療社, 東京, 2009; 99-100

[ 前へ戻る ][ TOPへ戻る ]